Back to Treatments

Treatment

Leukotriene Receptor Antagonists (LTRAs)

1
Conditions
200
Trials
30K
Participants
55%
Average Safety

Condition Evidence

Allergic Rhinitis

200 trials · 30K participants

65% effectiveness · 55% safety
Leukotriene Receptor Antagonists (LTRAs) | DFDA